Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPAR gamma/MMP-9 signals
Deng, G; Wang, RH; Sun, Y; Huang, CP; Yeh, SY; You, BS; Feng, CY; Li, GH; Ma, SL; Chang, C
Ma, SL (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hangzhou Peoples Hosp 1, Dept Urol, Hangzhou, Peoples R China.; Chang, C (corresponding author), Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.; Chang, C (corresponding author), Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.; Chang, C (corresponding author), Univ Rochester, Med Ctr, Dept Radiat Oncol, George Whipple Lab Canc Res, Rochester, NY
CELL DEATH AND DIFFERENTIATION, 2021; 28 (7): 2145
